DNMT3b Promoter Polymorphism and Risk of Gastric Cancer in the Korean Population

Kim, Sung Geun; Jung, Hun Soon; Kim, Sin Sun; Jeon, Kyung Hwa; Song, Kyo Young; Kim, Jin-Jo; Jin, Hyung Min; Kim, Wook; Park, Cho Hyun; Park, Seung Man; Lim, Keun Woo; Kim, Seung Nam; Jeon, Hae Myung

doi:10.5230/jkgca.2007.7.1.9

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A cohort study has reported that a sevenyear cumulative incidence of hyperuricemia was 23.1% in Korean male workers of 30~59 years of age in one of the largest semiconductor manufacturing companies in Korea [10]. The prevalence of hyperuricemia in 2002 was 9.3% among those who participated in the health check-up program [11]. A singlecenter study in a sample of 2,297 participants reported that the prevalence of hyperuricemia between 2008 and 2010 was 9.8% [12].…”

Section: Main Subjects Prevalence Of Hyperuricemiamentioning

confidence: 99%

Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean

Ahn

2023

J Rheum Dis

View full text Add to dashboard Cite

Gout is the most common form of inflammatory arthritis that affects mainly middle-aged men, and there is clear evidence of an association between hyperuricemia and the risk for gout. Increasing prevalence of gout and hyperuricemia has been reported in many countries. The prevalence of gout and hyperuricemia are constantly increasing in Korea with the patients at risk for developing a variety of comorbidities. Although there have been studies on the association between gout or serum uric acid level and several neurodegenerative diseases, cancer, and cardiovascular mortality, the causal relationship between gout and these comorbidities are still unclear. The associations of substantial economic burden with hyperuricemia, gout attack, and suboptimal treatment are well known. Gout is a disease that requires lifelong management including lifestyle modification. However, gout is poorly managed worldwide although effective urate-lowering drugs exist. In this review, we addressed epidemiological studies and treatment-related problems in the Korean population with gout or hyperuricemia to obtain the best clinical outcomes and reduce their medical burden.

show abstract

Section: Main Subjects Prevalence Of Hyperuricemiamentioning

confidence: 99%